Soybean JAG1 gene mutation
By introducing the mutated JAG1 gene into soybean plants, the problem of low growth efficiency of soybeans under extreme weather conditions is solved, water and nutrient utilization efficiency is improved, and efficient seed production and sustainability are achieved.
Patent Information
- Application Number
- CN202380028519.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-21
- Filing Date
- 2023-03-20
- Publication Date
- 2024-11-15
AI Technical Summary
Existing soybean varieties have low growth efficiency under extreme weather conditions and low water and nutrient management efficiency, which affects crop productivity and sustainability.
By introducing the mutated JAG1 gene, polypeptides encoding specific amino acid sequences in soy plant cells lead to the lack of JAG2 gene loss-of-function mutations in soy plants, thereby improving seed count and narrow leaf phenotype and enhancing the efficiency of water and nutrient utilization.
Efficient growth and water and nutrient management under extreme weather conditions have been achieved, the seed quantity and seed quality per kilogram of seeds have been improved, and the sustainability of soybean crops has been enhanced.
Smart Images

Figure CN118974261A_ABST
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This international patent application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 269,663, filed on March 21, 2022. Incorporation of Sequence Listing
[0002] The sequence listing contained in the file named "P13530WO00_ST26", which measures 71,751 bytes in the Windows operating system, was created on March 18, 2023 and electronically submitted via Patent Center on March 20, 2023, which is incorporated herein by reference in its entirety. Technical Field
[0003] Disclosed herein are nucleotide sequences in novel plants, plant parts, and soybean varieties comprising a mutated JAG1 gene, as well as methods of making them by growing soybean plants or batches, and methods of using them. Background Art
[0004] Agriculture is an important industry in the global economy, especially in the United States. Soybean (Glycine max) is an important leguminous crop worldwide due to its ability to fix atmospheric nitrogen. Soybean is a major source of protein in animal feed, and soybean oil is widely used in various industries, including food and beverage, biodiesel, and other industries.
[0005] Soy sustainability is a priority for farmers around the world. Agricultural practices such as water and nutrient management help farmers improve efficiency, increase crop productivity, conserve water, enrich soil quality, improve soil nutrient efficiency, and produce sustainable soybean crops. The benefits of bioengineering to soybean farmers include increased yields and the ability to withstand extreme weather. Summary of the invention
[0006] Disclosed herein are soybean plant cells comprising a mutated JAG1 gene, wherein the mutated JAG1 gene comprises a null mutation in the JAG1 gene encoding a polypeptide of SEQ ID NO: 10 or an allelic variant thereof, and wherein the soybean plant cell lacks a loss-of-function mutation in the soybean JAG2 gene. Also disclosed herein are soybean plant cells comprising a mutated JAG1 gene, wherein the mutated JAG1 gene encodes a polypeptide comprising an amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30 or an allelic variant thereof. In certain embodiments, the soybean plant cell is homozygous for the mutated JAG1 gene. In certain embodiments, the mutated JAG1 gene comprises a polynucleotide sequence of SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35 or an allelic variant thereof. In certain embodiments, the allelic variants of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30 are encoded by a JAG1 gene comprising a deletion corresponding to nucleotides 426 to 430, 424 to 430, or 423 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO: 1, respectively. Soybean plants, soybean plant parts, and soybean seeds comprising any of the aforementioned soybean plant cells or seeds, and soybean seed lots comprising the aforementioned soybean seeds are provided. A method for producing a soybean crop is provided, the method comprising planting a plurality of the aforementioned soybean seeds or the aforementioned seed lot. A method for producing a soybean by-product is provided, the method comprising at least one of the following processing steps: cleaning, cracking, flaking, crushing, macerating, pressing, extracting, draining, and / or extruding the aforementioned seed lot.
[0007] Provided are polynucleotides comprising a sequence of SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35 or an allelic variant thereof, or encoding a polypeptide comprising an amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30. Also provided are biological samples comprising the polynucleotides.
[0008] A method for producing a soybean seed lot is provided, the method comprising: (i) growing a population of soybean plants comprising a mutated JAG1 gene to maturity, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof, and wherein the soybean plants are homozygous for the mutated JAG1 gene; and (ii) harvesting seeds from the population of soybean plants of step (i) at maturity, thereby producing the soybean seed lot.
[0009] A method for preparing a soybean plant containing a mutated JAG1 gene is provided, the method comprising: (a) deleting: (i) nucleotides 426 to 430 of an endogenous soybean JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof in a wild-type soybean plant cell; (ii) nucleotides 424 to 430 of an endogenous soybean JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof in a wild-type soybean plant cell; or (iii) nucleotides 423 to 430 of an endogenous soybean JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof in a wild-type soybean plant cell; to obtain a modified soybean plant cell comprising the mutated JAG1 gene; and (b) recovering a soybean plant from the modified soybean plant cell. BRIEF DESCRIPTION OF THE DRAWINGS
[0010] Figure 1 The wild-type genomic DNA of the soybean JAG1 gene is shown (SEQ ID NO: 1). Exons are uppercase, introns are lowercase, and translation start and stop codons are uppercase, bold, italicized, and underlined.
[0011] Figure 2 A portion of wild-type JAG1 genomic DNA containing the end of the second exon and the start of the second intron of the soybean JAG1 gene is shown. The annotated wild-type DNA sequence (SEQ ID NO: 5) indicates the exon and translated sequence fragment (SEQ ID NO: 6) starting from Y17, the intron region is represented by lowercase letters, and the gRNA spacer complementary sequence is underlined. The deletions that cause frameshift mutations in the mJAG1 mutants of 1:5D (SEQ ID NO: 7), -2:7D (SEQ ID NO: 8), and -3:8D (SEQ ID NO: 9) are represented by replacing the deleted bases of the mutants with dashed lines. DETAILED DESCRIPTION definition
[0012] As used herein, the phrase "allelic variant" refers to polynucleotide or polypeptide sequence variations that occur in a particular gene of a particular locus in different strains, varieties or isolates of a given organism.
[0013] In addition, as used herein, the term "and / or" should be considered as a specific disclosure of each of the two specified features or components with or without each other. Therefore, the term "and / or" as used in phrases such as "A and / or B" herein is intended to include "A and B", "A or B", "A" (alone), and "B" (alone). Similarly, the term "and / or" as used in phrases such as "A, B, and / or C" is intended to cover each of the following embodiments: A, B and C; A, B or C; A or C; A or B; B or C; A and C; A and B; B and C; A (alone); B (alone); and C (alone).
[0014] As used herein, the phrase "biological sample" refers to complete or incomplete (e.g., ground soybean seeds or soybean plant tissue, chopped soybean plant tissue, freeze-dried tissue) soybean plant tissue. It can also be an extract comprising complete or incomplete seeds or soybean plant tissue. Biological samples can include flour, meal, syrup, oil, starch and cereals, all or part of which are manufactured to contain soybean plant by-products. In certain embodiments, the biological sample is "non-renewable" (i.e., cannot be regenerated into soybean plants or soybean plant parts).
[0015] For example, the terms "corresponding," "corresponding," and the like, when used in the context of nucleotide positions, mutations and / or substitutions of any given polynucleotide (e.g., an allelic variant of SEQ ID NO: 1) relative to a reference polynucleotide sequence (e.g., SEQ ID NO: 1), all refer to the positions of polynucleotide residues in a given sequence that are identical to residues in a reference nucleotide sequence when the given polynucleotide is aligned to the reference polynucleotide sequence using a pairwise alignment algorithm (e.g., CLUSTAL O 1.2.4 with default parameters).
[0016] As used herein, the terms "Cpf1" and "Cas12a" are used interchangeably to refer to the same RNA-dependent DNA endonuclease (RdDe).
[0017] As used herein, the phrase "endogenous gene" refers to the native form of a gene in the genome of an organism.
[0018] As used herein, the terms "include, includes and including" should be interpreted as having at least the characteristics they refer to without excluding any additional unspecified characteristics. As used herein, the term "plant" includes reference to immature or mature whole soybean plants, including plants from which seeds or grains or anthers have been removed. Any seed or embryo that will produce a plant is also considered a soybean plant.
[0019] As used herein, the phrase "loss of function" mutation or allele of a gene refers to a gene mutation or allele that exhibits reduced gene function compared to the unmutated or wild-type allele of the gene. Therefore, a "loss of function" mutation includes mutations that result in both null (i.e., amorphous) alleles and hypomorphic alleles (i.e., reduced due to uneliminated function) of a gene.
[0020] As used herein, the phrase "mutated JAG1 gene" or "mJAG1 gene" refers to an endogenous soybean JAG1 gene comprising a null mutation. In certain embodiments, the mJAG1 comprising a null mutation encodes a polypeptide of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof, wherein the allelic variant of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, or 30 comprises a deletion corresponding to a deletion of amino acid residues encoded by nucleotides 426 to 430, 424 to 430, or 423 to 430, respectively, of the endogenous soybean JAG1 gene of SEQ ID NO: 1. In certain embodiments, the mJAG1 deletion is a null mutation comprising a deletion corresponding to at least nucleotides 421 to 436 of SEQ ID NO: 1.
[0021] As used herein, a null mutation of a gene refers to an allele of a gene that does not have gene activity compared to the wild-type allele of the gene. Null alleles are also called amorphous alleles.
[0022] As used herein, the term "plant" includes the entire soybean plant and any progeny, cell, tissue, one or more parts of the plant. Thus, the term "plant" includes reference to immature or mature whole soybean plants, including plants from which seeds or grains or anthers have been removed.
[0023] The term "plant part" includes any one or more parts of a plant, including, for example, but not limited to: seeds (including mature seeds and immature seeds); grains; stalks; plant cuttings; plant cells; plant cell cultures; or plant organs (e.g., pollen, embryos, pods, flowers, fruits, buds, leaves, roots, stems, and explants). Plant tissues or plant organs can be seeds, protoplasts, callus, or any other plant cell groups organized into structural or functional units. Plant cells or tissue cultures can be capable of regenerating plants with physiological and morphological characteristics of the plants from which the cells or tissues are obtained, and can regenerate plants with substantially the same genotype as the plants. Regenerable cells in plant cells or tissue cultures can be embryos, protoplasts, meristem cells, callus, pollen, leaves, anthers, roots, root tips, flowers, or stalks. In contrast, some plant cells cannot be regenerated to produce plants, and are referred to herein as "non-regenerable" plant cells.
[0024] To the extent that any of the foregoing definitions are inconsistent with definitions provided in any patent or non-patent reference incorporated herein by reference, any patent or non-patent reference cited herein, or any patent or non-patent reference found elsewhere, it should be understood that the foregoing definitions will control herein.
[0025] The present disclosure provides soybean plant cells, plant parts including seeds, plants and biological samples comprising the mJAG1 gene. These mJAG1 plants and parts can be used for human food, livestock feed, as industrial raw materials or as breeding materials for developing other soybean varieties. The target endogenous JAG1 gene comprises genomic DNA of SEQ ID NO:1 and its allelic variants located on soybean chromosome 20. The endogenous soybean JAG1 gene is located at nucleotides 35827671 to 35830107 of chromosome 20 of soybean Wm82.a2.v1 shown in the https Internet website "phytozome-next.jgi.doe.gov / report / transcript / Gmax_Wm82_a2_v1 / Glyma.20G116200.1". Allelic variants of the endogenous soybean JAG1 gene include variants encoding JAG1 proteins having at least 95%, 96%, 98%, 99% or 99.5% sequence identity with SEQ ID NO:10. Allelic variants of the endogenous soybean JA G1 gene also include variants comprising genomic DNA having at least 95%, 96%, 98%, 99% or 99.5% sequence identity to SEQ ID NO: 1. In certain embodiments, the mJAG1 gene may encode a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30 or an allelic variant thereof. In certain embodiments, such allelic variants of SEQ ID NO: 12, 13 or 14 may comprise an amino acid sequence having at least 95%, 96%, 98%, 99% or 99.5% sequence identity to the full length of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28 and 30. In certain embodiments, such allelic variants of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28 or 30 may comprise an amino acid sequence having at least 95%, 96%, 98%, 99% or 99.5% sequence identity to the full length of SEQ ID NO: 12, 13 and 14, and are encoded by a JAG1 gene comprising a deletion corresponding to nucleotides 426 to 430, 424 to 430 or 423 to 430, respectively, of the endogenous soybean JAG1 gene of SEQ ID NO: 1. In certain embodiments, the mJAG1 gene may comprise a JAG1 gene or the aforementioned allelic variants thereof comprising a deletion corresponding to nucleotides 426 to 430, 424 to 430 or 423 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO: 1. In certain embodiments, the mJAG1 deletion is a null mutation comprising a deletion corresponding to at least nucleotides 421 to 436 of SEQ ID NO: 1 or an allelic variant thereof.
[0026] In certain embodiments, soybean plant cells, plants, plant parts and seeds comprising a mJAG1 null allele of the JAG1 gene lack a loss-of-function mutation (e.g., a null mutation) in the soybean JAG2 gene. The wild-type endogenous soybean JAG2 gene (referred to as GmJAG2) comprises genomic DNA of SEQ ID NO:36 or an allelic variant thereof located on soybean chromosome 10. The endogenous soybean JAG2 gene is located at nucleotides 49647129 to 49649853 of chromosome 10 of the soybean Wm82.a2.v1 genome under the gene identifier Glyma.10g273800 as shown in the https internet website "soybase.org" and comprises the coding sequence of SEQ ID NO:37 encoding the wild-type JAG2 protein of SEQ ID NO:38. Soybean plant cells, plants, plant parts and seeds lacking a loss-of-function mutation (e.g., a null mutation) in the soybean JAG2 gene can be identified by at least sequencing a region of their genomic DNA corresponding to SEQ ID NO:36.
[0027] In certain embodiments, the mJAG1 null allele of the JAG1 gene provided herein will provide a soybean plant exhibiting a narrow leaf phenotype and an increased number of seeds per kilogram of seed, the seeds being harvested from a soybean plant homozygous for the null allele of the mJAG1 gene, wherein the narrow leaf phenotype and the increased number of seeds per kilogram of seed harvested are both compared to the leaf phenotype of a corresponding control soybean plant lacking the mJAG1 gene (e.g., a wild-type soybean plant homozygous for the wild-type JAG1 gene) and the number of seeds per kilogram of seed harvested therefrom. In certain embodiments, a soybean plant homozygous for the mJAG1 null allele will lack a loss-of-function mutation in the soybean JAG2 gene and will exhibit the aforementioned narrow leaf and increased number of seeds per kilogram of seed phenotype compared to a control plant.
[0028] In certain embodiments, a soybean plant that is homozygous for the mJAG1 gene can produce a seed lot in which the number of seeds per kilogram of seeds harvested from the soybean plant that is homozygous for the mJAG1 gene is increased compared to the number of seeds per kilogram harvested from a corresponding control soybean plant that lacks the mJAG1 gene (e.g., a wild-type soybean plant that is homozygous for the wild-type JAG1 gene). In certain embodiments, the number of seeds per kilogram of seeds harvested from a soybean plant that is homozygous for the mJAG1 gene is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, or 12% compared to the number of seeds per kilogram harvested from a corresponding control soybean plant that lacks the mJAG1 gene (e.g., a wild-type soybean plant that is homozygous for the wild-type JAG1 gene). In certain embodiments, the number of seeds per kilogram of seeds harvested from a soybean plant that is homozygous for the mJAG1 gene is increased by about 1% or 2% to any of about 5%, 6%, 7%, 8%, 9%, 10%, or 12% compared to the number of seeds per kilogram harvested from a corresponding control soybean plant lacking the mJAG1 gene (e.g., a wild-type soybean plant that is homozygous for the wild-type JAG1 gene). In certain embodiments, the weight per 1000 seeds (in grams) harvested from a soybean plant that is homozygous for the mJAG1 gene is reduced by up to about 2%, 4%, 6%, 8%, 9%, 10%, or 11% compared to the weight per 1000 seeds (in grams) harvested from a corresponding control soybean plant lacking the mJAG1 gene (e.g., a wild-type soybean plant that is homozygous for the wild-type JAG1 gene). In certain embodiments, the weight per 1000 seeds harvested from a soybean plant homozygous for the mJAG1 gene is reduced by up to about 2%, 4%, 6%, 8%, 9%, 10%, or 11% compared to the weight per 1000 seeds harvested from a corresponding control soybean plant lacking the mJAG1 gene (e.g., a wild-type soybean plant homozygous for the wild-type JAG1 gene). In certain embodiments of any of the foregoing seed lots, the mJAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12 or an allelic variant thereof. In certain embodiments, such an allelic variant of SEQ ID NO: 12 may comprise an amino acid sequence having at least 95%, 96%, 98%, 99%, or 99.5% sequence identity to the full length of SEQ ID NO: 12. In certain embodiments, such an allelic variant of SEQ ID NO: 12 may comprise an amino acid sequence having at least 95%, 96%, 98%, 99% or 99.5% sequence identity to the full length of SEQ ID NO: 12 and is encoded by an mJAG1 gene comprising a deletion corresponding to nucleotides 426 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO: 1.In certain embodiments, the mJAG1 gene may comprise an mJAG1 gene or a foregoing allelic variant thereof comprising a deletion corresponding to nucleotides 426 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO:1.
[0029] Also provided herein are polynucleotides comprising any of the foregoing mJAG1 genes or fragments thereof. In certain embodiments, polynucleotides comprising the sequence of SEQ ID NO:7, 8, 9, 15, 16, 17, 18, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34, 35, or an allelic variant thereof are provided. In certain embodiments, an allelic variant of SEQ ID NO:7, 8, or 9 will comprise a sequence having at least 95%, 97%, 98%, 99%, or 99.5% sequence identity to the full length of SEQ ID NO:7, 8, 9, 15, 16, 17, 18, or 19, provided that the sequence is not identical to SEQ ID NO:1 over its full length and comprises a deletion corresponding to nucleotides 426 to 430, 424 to 430, or 423 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO:1. In certain embodiments, an allelic variant of SEQ ID NO: 21, 23, 25, 27, 29, 31, 32, 33, 34, or 35 will comprise a sequence having at least 95%, 97%, 98%, 99%, or 99.5% sequence identity to the full length of SEQ ID NO: 21, 23, 25, 27, 29, 31, 32, 33, 34, 35, provided that the sequence is not identical to SEQ ID NO: 1 over its full length and comprises a deletion in the SEQ ID NO: 1 sequence corresponding to the deletion of SEQ ID NO: 21, 23, 25, 27, or 29. In certain embodiments, the polynucleotide encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof. In certain embodiments, the encoded allelic variant will comprise a polypeptide having at least 95%, 97%, 98%, 99% or 99.5% sequence identity to the full length of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28 or 30, provided that the sequence is not identical to SEQ ID NO: 10. In certain embodiments, the polynucleotide is an isolated polynucleotide. Also provided are biological samples and soybean byproducts comprising any of the aforementioned polynucleotides. In certain embodiments, the by-products are processed products made from mJAG1 soybean plants or their seeds, including: (a) soybean seed meal (defatted or not defatted); (b) extracted soy protein, oil, sugar, syrup, and starch; (c) soybean fermentation products; (d) soy-based animal feed or human food (e.g., feed and food containing soybean seed meal (defatted or not defatted) and other ingredients (e.g., other grains, other seed meals, other protein meals, other oils, other starches, other sugars, binders, preservatives, humectants, vitamins, and / or minerals)); (e) pharmaceuticals; (f) raw or processed biomass (e.g., cellulosic and / or lignocellulosic materials; silage); and (g) various industrial products.
[0030] Also provided are methods of producing soybean byproducts using mJAG1 soybean plants, seeds, and seed lots.Such methods will typically include at least one of the following processing steps: cleaning, cracking, flaking, crushing, macerating, pressing, extracting, draining, and / or extruding the seeds.
[0031] The present disclosure also relates to a method of producing a soybean plant having a mutated JAG1 gene by crossing a first parent soybean plant with a second parent soybean plant, wherein the first parent soybean plant or the second parent soybean plant is an mJAG1 plant. In addition, both the first parent soybean plant and the second parent soybean plant can be from an mJAG1 plant. Still further, the present disclosure also relates to a method of producing a soybean plant derived from an mJAG1 plant by crossing an mJAG1 plant with a soybean plant, growing progeny seeds, and repeating the crossing and growing steps performed using a soybean plant derived from an mJAG1 plant 1 to 2 times, 1 to 3 times, 1 to 4 times, or 1 to 5 times. Therefore, any such method using an mJAG1 plant is part of the present disclosure: selfing, backcrossing, hybridization production, population hybridization, etc. All plants produced using an mJAG1 plant as a parent are within the scope of the present disclosure, including plants derived from an mJAG1 plant having a mutated JAG1 gene. Also provided are F1 progeny soybean plants, F1 seeds, and various parts of F1 soybean plants produced by crossing a soybean plant containing mJAG1 (eg, a plant homozygous for the mJAG1 gene) with any other soybean plant.
[0032] Breeding methods that can be used with mJAG1 plants in the development of additional soybean plants are described below. One such embodiment is a method for developing mJAG1 progeny soybean plants in a soybean plant breeding program, the method comprising: obtaining a soybean plant or part thereof of an mJAG1 plant, and utilizing the plant or plant part as a source of breeding material; and selecting mJAG1 progeny plants having a mutated JAG1 (mJAG1) gene. Breeding steps that can be used in a soybean plant breeding program include pedigree breeding, backcrossing, mutation breeding, and recurrent selection. In conjunction with these steps, techniques such as restriction fragment polymorphism enhanced selection, genetic marker enhanced selection (e.g., SSR markers), and preparation of doubled haploids can be utilized.
[0033] Another method involves producing a population of mJAG1 progeny soybean plants, the method comprising crossing an mJAG1 plant with another soybean plant, thereby producing a population of soybean plants having an average of 50% of alleles from the mJAG1 plant. The mJAG1 plants of the population can be selected and repeatedly selfed or sib-crossed with soybean varieties produced from these successive progeny. An embodiment of the present disclosure is a soybean variety produced by this method, and the soybean variety has obtained at least 50% of its alleles from mJAG1.
[0034] Field crops are cultivated by utilizing the technology of plant pollination methods. According to the present disclosure, mJAG1 plants can be hybridized with self-pollination, sibling pollination or cross-pollination to produce pedigree soybean plants. If pollen from one flower is transferred to the same or another flower of the same plant, the plant is self-pollinated. When individuals within the same family or variant are used for pollination, the plant is sibling-pollinated. If pollen comes from flowers on different plants of different families or variants, the plant is cross-pollinated. As used herein, the terms "cross-pollination" and "outcrossing" do not include self-pollination or sibling pollination. Soybean plants (soybeans) are considered to be naturally self-pollinating plants, which, although they are capable of cross-pollination, rarely do so in nature. Some researchers report that insects carry pollen from one soybean plant to another soybean plant, and it is generally estimated that less than 1% of soybean seeds formed in open-air planting can be traced back to cross-pollination, i.e., less than 1% of soybean seeds formed in open-air planting can produce F1 hybrid soybean plants.
[0035] Any other suitable breeding, selection or growing method may be used. The choice of a particular breeding or selection method will vary depending on environmental factors, population size, etc.
[0036] In certain embodiments, soybean plant cells, plant parts (e.g., seeds) and plants comprising the mJAG1 gene and a transgenic locus are provided. In one embodiment, the mBS1 or mBS1 gene is combined with one or more soybean GM events that provide tolerance to any one or a combination of glyphosate-based, glufosinate-based, HPPD inhibitor-based, sulfonylurea or imidazolinone-based, AHAS or ALS-inhibitory and / or auxin-based (e.g., dicamba, 2,4-D) herbicides and / or insect resistance traits, such as event EE-GM3 (aka FG-072, Described in WO 2011063411, USDA-APHIS Petition 09-328-01p), Event SYHTOH2 (aka 0H2, described in WO 2012 / 082548 and 12-215-01p), Event DAS-68416-4 (aka Enlist soybean, described in WO 2011 / 066384 and WO 2011 / 066360, USDA-APHIS Petition 09-349-01p), Event DAS-44406-6 (aka Enlist E3, described in WO 2012 / 075426 and USDA-APHIS 11-234-01p), event MON87708 (a dicamba tolerance event for Roundup Ready 2Xtend soybeans, described in WO 2011 / 034704 and USDA-APHIS Petition 10-188-01p, ), Event MON89788 (aka Genuity RoundupReady2Yield, described in WO 2006 / 130436 and USDA-APHIS Petition 06-178-01p), Event 40-3-2 (aka Roundup Ready, GTS 40-3-2, described in USDA-APHIS Petition 93-258-01), Incident A2704-12 (aka LL27, described in WO 2006108674 and USDA-APHIS Petition 96-068-01p), Event 127 (aka BPS-CV127-9, described in WO 2010 / 080829), Event A5547-127 (aka LL55, Described in WO 2006108675 and USDA-APHIS Petition 96-068-01p), Event MON87705 ( Vistive Gold, published PCT patent application WO 2010 / 037016, USDA-APHIS petition 09-201-01p), or event DP305423 (aka Published PCT Patent Application WO 2008 / 054747, USDA-APHIS Petition 06-354-01p), or EE-GM5 in combination with a combination of the following events: Event MON98788×MON87708 (aka Roundup Ready 2Xtend soybean, -9×MON-89788-1), Event HOS×Event 40-3-2 (aka Plenish High Oleic Soybean×Roundup Ready Soybean), Event EE-GM3×EE-GM2 (aka FG-072xLL55, described in WO 2011063413), Event MON 87701×MON89788 (aka Intacta RR2 Pro Soybean, -2×MON-89788-1), DAS-81419-2×DAS-44406-6 (aka Conkesta TM Enlist E3 TM Soybean, DAS-81419-2× -6), Event DAS-68416-4 x Event MON 89788 (aka Enlist TM RoundUp 2 soybeans, DAS-68416-4×MON-89788-1), event MON-87769-7×event MON-89788-1 (akaω-3×Genuity Roundup Ready2Yield soybeans), event MON 87705×event MON 89788 (aka Vistive Gold, -6×MON-89788-1) or event MON87769×event MON89788 (akaω-3×Genuity Roundup Ready2Yield soybean, MON-87769-7×MON-89788-1), wherein all published PCT patent applications or their U.S. national phases are incorporated herein by reference in their entirety. Representative transgenic events that can be combined with the mJAK1 gene include those shown in Table 1. Also provided herein are modified soybean plant cells, plant parts (e.g., seeds), and plants comprising the mJAG1 gene and any of the aforementioned transgenic events or the transgenic events shown in Table 1 below. Modifications of transgenic events include those disclosed in WO 2022 / 026375, WO 2022 / 026379, WO 2022 / 026390, WO 2022 / 026395, WO2022 / 026403, U.S. Patent Application Publication No. US 20220030822, and U.S. Patent No. 11,242,534, each of which is herein incorporated by reference in its entirety. Table 1. Transgenic soybean events 1Traits: IR = insect resistance; HT = herbicide tolerance; AR = antibiotic resistance; 2 Each US patent or patent application publication is incorporated herein by reference in its entirety. 3 ATCC is the American Type Culture Collection, 10801 University Avenue, Manassas, VA 20110 USA (for "PTA-XXXXX" deposits). 4 NCIMB is the National Collection of Industrial, Food and Marine Bacteria, Ferguson Building, Craibstone Estate, Bucksburn, Aberdeen AB 9YA, Scotland. 5 HT against: 2,4-D; glyphosate and glufosinate; also known as pDAB8264.44.06.1. 6 Independent IR / HT and HT events were combined by breeding. The IR / HT event (Cry1F, Cry1Ac synpro(Cry1Ac), and PAT) is DAS81419-2, deposited with the ATCC as PTA-12006, also known as DAS81419-2. 7 Elk Mound Seed, 308 Railroad Street, Elk Mound, Wisconsin, USA 54739. 8 HT against dicamba. 9 HT for glyphosate and isoflurane herbicides. 10 HT for glufosinate and mesotrione herbicides.
[0037] In certain embodiments, the mutated Jag1 gene is combined with a null mutation in the soybean TFL1b gene, which is an ortholog of the Arabidopsis Terminal Flower 1 gene. The soybean TFL1b ortholog is found in the https internet database "soybase.org" as Glyma.19G194300 and is also known as the soybean stem growth habit gene Dt1 (Liu et al. Plant Physiol. 2010 May; 153(1): 198-210. doi: 10.1104 / pp.109.150607. Electronically published on March 10, 2010. PMID: 20219831; PMCID: PMC2862436). TFL1b wild-type genomic DNA is provided as SEQ ID NO: 39, TFL1b wild-type coding sequence is provided as SEQ ID NO: 40, and TFL1b protein is provided as SEQ ID NO: 41. Null mutations in TFL1b can be obtained by gene editing technology (e.g., by using CRISPR / Cas9, CRISPR / Cas12, TALEN or aZFN-mediated site-specific mutagenesis of the TFL1b gene).
[0038] A method of producing a soybean seed lot, the method comprising: (i) growing a population of soybean plants comprising an mJAG1 gene to maturity; and (ii) harvesting seeds from the soybean plant population of step (i) at maturity, thereby producing the soybean seed lot, wherein the soybean plants are homozygous for the mutated JAG1 gene. In certain embodiments, the seed lot is packaged in a batch containing about 50 to 60 pounds (e.g., about 22.7 to 27.2 kilograms). In certain embodiments, a seed lot consisting of seeds homozygous for certain mJAG1 mutations will contain more seeds than a control seed lot obtained from a control soybean comprising a wild-type JAG1 gene. In certain embodiments, there will be up to about 2%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% more seeds in a seed lot consisting of seeds homozygous for certain mJAG1 mutations compared to a control seed lot obtained from a control soybean comprising a wild-type JAG1 gene. Also provided herein are methods for treating mJAG1 seeds and seed batches and the resulting treated mJAG1 seeds and seed batches. Such fertilizers, biopharmaceuticals, nematicides, insecticides and fungicides can be used by methods including in-ditch application or by coating (e.g., with a drum coater, a rotary coater, a tumbling cylinder, a fluidized bed and / or a spouted bed apparatus) to treat seeds. Methods and compositions for coating seeds that can be applied to seeds provided herein are disclosed in U.S. Patent No. 10745578, which is incorporated herein by reference in its entirety, including various adhesives, fillers, film coatings and active ingredients, such as fertilizers, surfactants, plant growth regulators, crop desiccants, fungicides, bactericides, bacterial inhibitors, insecticides and insect repellents.
[0039] The present disclosure also provides a method for preparing a soybean plant containing a mutated JAG1 gene. In certain embodiments, the method may include preparation of a deletion or a combination of deletion and insertion and / or substitution, thereby generating an mJAG1 gene encoding a polypeptide of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30 or its allelic variant. The gene editing molecules used in the methods provided herein include molecules capable of introducing double-strand breaks ("DSBs") or single-strand breaks ("SSBs") in double-stranded DNA, such as in genomic DNA or a target gene located in genomic DNA and an accompanying guide RNA at a specific site or sequence. In certain embodiments, the mJAG1 allele is derived from the introduction of a DSB at a target site in a JAG1 gene (e.g., SEQ ID NO: 1 or its allelic variant) to induce non-homologous end joining (NHEJ) at the break site, followed by recovery of the desired mJAG1 allele. In certain embodiments, the mJAG1 allele is derived from the introduction of a DSB at a target site in a JAG1 gene (e.g., SEQ ID NO: 1 or an allelic variant thereof), followed by homology directed repair (HDR), microhomology-mediated end joining (MMEJ), or NHEJ to introduce a desired donor or other DNA template polynucleotide at the DSB, followed by recovery of the desired mJAG1 allele.Examples of such gene editing molecules include: (a) nucleases, including RNA-guided nucleases, RNA-guided DNA endonucleases or RNA-guided DNA endonucleases (RdDe), class 1 CRISPR-type nuclease systems, type II Cas nucleases, Cas9, nCas9 nickases, type V Cas nucleases, Cas12a nucleases, nCas12a nickases, Cas12d (CasY), Cas12e (CasX), Cas12b (C2c1), Cas12c (C2c3), Cas12i, Cas12j, Cas14, engineered nucleases, codon-optimized nucleases, zinc finger nucleases (ZFNs) or nickases, transcription activator-like effector nucleases (TAL-effector nucleases or TALENs) or nickases (T-effector nucleases); The invention relates to a method for preparing a genomic DNA template comprising: (a) a nucleic acid sequence of at least one nucleotide ... In certain embodiments, the method may include: (a) deleting: (i) nucleotides 426 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO: 1 or its allelic variant in a wild-type soybean plant cell; (ii) nucleotides 424 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO: 1 or its allelic variant in a wild-type soybean plant cell; or (iii) nucleotides 423 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO: 1 or its allelic variant in a wild-type soybean plant cell; to obtain a modified soybean plant cell comprising the mutated JAG1 gene; and (b) recovering a soybean plant from the modified soybean plant cell.
[0040] In certain embodiments, the mJAG1 gene and plant cells, parts including seeds, and plants comprising the mJAG1 gene are generated by CRISPR technology. CRISPR technology for editing genes in eukaryotic organisms is disclosed in U.S. Patent Application Publication Nos. 2016 / 0138008A1 and 2015 / 0344912A1 and U.S. Patents Nos. 8,697,359, 8,771,945, 8,945,839, 8,999,641, 8,993,233, 8,895,308, 8,865,406, 8,889,418, 8,871,445, 8,889,356, 8,932,814, 8,795,965, and 8,906,616. Cpf1 endonucleases and corresponding guide RNAs and PAM sites are disclosed in U.S. Patent Application Publication 2016 / 0208243A1. Plant RNA promoters for expressing CRISPR guide RNAs and plant codon-optimized CRISPR Cas9 endonucleases are disclosed in International Patent Application PCT / US2015 / 018104 (published as WO2015 / 131101 and claiming priority to U.S. Provisional Patent Application 61 / 945,700). Methods for genome editing using CRISPR technology in plants are disclosed in U.S. Patent Application Publications US 2015 / 0082478A1 and US2015 / 0059010A1 and International Patent Application PCT / US2015 / 038767A1 (published as WO 2016 / 007347 and claiming priority to U.S. Provisional Patent Application 62 / 023,246). In certain embodiments, RNA-guided endonucleases are used that leave blunt ends after cleaving the target site. Blunt-end-cutting RNA-guided endonucleases include Cas9, Cas12c, Cas12i, and Cas12h (Yan et al., 2019). In certain embodiments, RNA-guided endonucleases are used that leave staggered single-stranded DNA overhangs after cleaving the target site. Staggered-end-cutting RNA-guided endonucleases include Cas12a, Cas12b, and Cas12e. The non-restrictive target Cas12 cleavage site region in the JAG1 gene shown in SEQ ID NO: 1 and SEQ ID NO: 5 is Figure 2Indicated in. A guide RNA comprising a spacer RNA encoded by SEQ ID NO: 2 can be used in combination with a Cas12 nuclease to generate an mJAG1 gene that: (i) encodes a polypeptide of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof; (ii) comprises a deletion in an endogenous JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof corresponding to a deletion in SEQ ID NO: 7, 8, 9, 21, 23, 25, 27, 29, 31, 32, 33, 34, 35, or an allelic variant thereof; and / or (ii) comprises a deletion of nucleotides 426 to 430 of an endogenous soybean JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof in a wild-type soybean plant cell, a deletion of nucleotides 424 to 430 of an endogenous soybean JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof, or a deletion of nucleotides 506 to 511 of an endogenous soybean JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof in a wild-type soybean plant cell. NO: A deletion of nucleotides 423 to 430 of the endogenous soybean JAG1 gene of 1 or an allelic variant thereof. All patent publications cited in this paragraph are incorporated herein by reference in their entirety.
[0041] CRISPR type genome editing can be applied to plant cells and methods provided herein in several ways.CRISPR elements, such as gene editing molecules comprising CRISPR endonucleases and CRISPR guide RNAs (including single guide RNAs or guide RNAs combined with tracrRNA or scoutRNA, or polynucleotides encoding them), can be used to achieve genome editing without residues of CRISPR elements or selective genetic markers in progeny.In certain embodiments, CRISPR elements are provided directly to eukaryotic cells (e.g., soybean plant cells), systems, methods and compositions as separated molecules, as separation or semi-purified products of cell-free synthesis processes (e.g., in in vitro translation), or as separation or semi-purified products of cell-based synthesis processes (e.g., as in bacteria or other cell lysates).In certain embodiments, soybean plants or soybean plant cells used in systems, methods and compositions provided herein may include transgenics expressing CRISPR endonucleases (e.g., Cas9, Cpf1 type or other CRISPR endonucleases).In certain embodiments, one or more CRISPR endonucleases with unique PAM recognition sites may be used. The guide RNA (sgRNA or crRNA and tracrRNA) forms an RNA-guided endonuclease / guide RNA complex that can specifically bind to a sequence adjacent to the protospacer adjacent motif (PAM) sequence in the gDNA target site. The type of RNA-guided endonuclease typically informs the location of a suitable PAM site and the design of crRNA or sgRNA. G-rich PAM sites, e.g., 5'-NGG, are typically targeted for designing crRNA or sgRNA for use with Cas9 protein. Examples of PAM sequences include 5'-NGG (Streptococcus pyogenes), 5'-NNAGAA (Streptococcus thermophilus CRISPR1), 5'-NGGNG (Streptococcus thermophilus CRISPR3), 5'-NNGRRT or 5'-NNGRR (Staphylococcus aureus Cas9, SaCas9) and 5'-NNNGATT (Neisseria meningitidis). T-rich PAM sites (e.g., 5'-TTN or 5'-TTTV, where "V" is A, C or G) are typically targeted for designing crRNA or sgRNA for use with Cas12 proteins. In some cases, Cas12 nucleases (e.g., Cas12a) can also recognize 5'-CTA PAM motifs.Other examples of potential Cas12 PAM sequences include TTN, CTN, TCN, CCN, TTTN, TCTN, TTCN, CTTN, ATTN, TCCN, TTGN, GTTN, CCCN, CCTN, TTAN, TCGN, CTCN, ACTN, GCTN, TCAN, GCCN, and CCGN (wherein N is defined as any nucleotide). Cpf1 endonuclease and corresponding guide RNA and PAM site are disclosed in U.S. Patent Application Publication No. 2016 / 0208243A1, and the DNA encoding Cpf1 endonuclease and guide RNA and PAM site disclosed therein are incorporated herein by reference.
[0042] In certain embodiments, the mJAG1 gene and plant cells, parts including seeds, and plants comprising the mJAG1 gene are generated by using zinc finger nucleases or zinc finger nickases. Zinc finger nucleases are site-specific endonucleases that contain two protein domains: a DNA binding domain that contains a plurality of individual zinc finger repeats, each of which recognizes 9 to 18 base pairs, and a DNA cleavage domain that contains a nuclease domain (typically Fok1). The cleavage domains dimerize to cleave DNA; therefore, a pair of ZFNs is required to target a non-palindromic target polynucleotide. In certain embodiments, the zinc finger nuclease and zinc finger nickase design methods described (Urnov et al. (2010) Nature Rev. Genet., 11:636–646; Mohanta et al. (2017) Genes 8, 12:399; Ramirez et al. Nucleic Acids Res. (2012); 40(12):5560–5568; Liu et al. (2013) Nature Communications, 4:2565) can be adapted for use in the methods described herein. The zinc finger binding domain of a zinc finger nuclease or nickase provides specificity and can be engineered to specifically recognize any desired target DNA sequence. The zinc finger DNA binding domain is derived from the DNA binding domain of a large class of eukaryotic transcription factors called zinc finger proteins (ZFPs). The DNA binding domain of a ZFP typically contains a tandem array of at least three zinc "fingers", each of which recognizes a specific DNA triplet. Many strategies can be used to design the binding specificity of zinc finger binding domains. A method called "modular assembly" relies on the functional autonomy of a single zinc finger with DNA. In this method, a given sequence is targeted by identifying the zinc fingers of each triplet component in the sequence and connecting them into a multi-finger peptide. Several alternative strategies for designing zinc finger DNA binding domains have also been developed. These methods are designed to adapt to the ability of zinc fingers to contact adjacent fingers and nucleotide bases outside their target triplet. Typically, compared to naturally occurring zinc finger proteins, engineered zinc finger DNA binding domains have new binding specificity. Engineering methods include, for example, rational design and various types of selection. Rational design includes, for example, using a database of triplet (or quadruple) nucleotide sequences and single zinc finger amino acid sequences, wherein each triplet or quadruple nucleotide sequence is associated with one or more amino acid sequences of zinc fingers that bind to a specific triplet or quadruple sequence. See, for example, U.S. Patents 6,453,242 and 6,534,261, both of which are incorporated herein by reference in their entirety. Exemplary selection methods (eg, phage display and yeast two-hybrid systems) can be adapted for use with the methods described herein.In addition, enhancing the binding specificity of zinc finger binding domains has been described in U.S. Pat. No. 6,794,136, which is incorporated herein by reference in its entirety. In addition, any suitable linker sequence can be used to connect individual zinc finger domains together. Examples of linker sequences are well known, for example, see U.S. Pat. Nos. 6,479,626; 6,903,185; and 7,153,949, which are incorporated herein by reference in their entirety. Nucleic acid cleavage domains are non-specific and are typically restriction endonucleases, such as Fok1. Such endonucleases must dimerize to cleave DNA. Therefore, cleavage by Fok1 as part of a ZFN requires two adjacent and independent binding events, which must occur in the correct orientation and at appropriate intervals to allow dimer formation. The requirement for two DNA binding events enables more specific targeting of long and potentially unique recognition sites. Fok1 variants with enhanced activity have been described and may be suitable for use in the methods described herein; see, e.g., Guo et al. (2010) J. Mol. Biol., 400:96-107.
[0043] In certain embodiments, the mJAG1 gene and plant cells, parts including seeds, and plants comprising the mJAG1 gene are generated by using TAL-effector nucleases or TALENs. Transcription activator-like effectors (TALEs) are proteins secreted by certain Xanthomonas species to regulate gene expression in host plants and promote bacterial colonization and survival. TALEs act as transcription factors and regulate the expression of resistance genes in plants. Recent studies on TALEs have revealed a code that connects the repeat region of TALE to its target DNA binding site. TALEs contain highly conserved and repetitive regions, consisting of tandem repeats of mostly 33 or 34 amino acid segments. The repeating monomers differ from each other primarily at amino acid positions 12 and 13. It has been found that there is a strong correlation between the unique amino acid pairs at positions 12 and 13 and the corresponding nucleotides in the TALE binding site. The simple relationship between the amino acid sequence and the DNA recognition of the TALE binding domain allows the design of any desired specific DNA binding domain. TALEs can be linked to non-specific DNA cleavage domains to make genome editing proteins, called TAL effector nucleases or TALENs. As in the case of ZFNs, restriction endonucleases such as Fokl can be conveniently used. Methods for using TALENs in plants have been described and can be adapted for the methods described herein, see Mahfouz et al. (2011) Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences of the United States], 108: 2623–2628; Mahfouz (2011) GM Crops [Transgenic Crops], 2: 99-103; and Mohanta et al. (2017) Genes [Gene] Vol. 8, 12: 399. TALE nickases have also been described and may be adapted for use in the methods described herein (Wu et al.; Biochem Biophys Res Commun. (2014); 446(1):261-6; Luo et al.; Scientific Reports 6, article number: 20657 (2016)). Example
[0044] The present disclosure provides soybean plants and plant parts comprising a mutated JAG1 gene, and methods of making and using the same. Non-limiting examples of the present disclosure are provided herein, as follows:
[0045] (1) A soybean plant cell comprising a mutated JAG1 gene, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14 or an allelic variant thereof, optionally wherein the plant cell is homozygous for the mutated JAG1 gene.
[0046] (2) The soybean plant cell of embodiment 1, wherein the mutated JAG1 gene comprises: (i) a polynucleotide sequence of SEQ ID NO: 7, 8 or 9; or (ii) wherein the allelic variant of SEQ ID NO: 12, 13 or 14 is encoded by a JAG1 gene comprising a deletion corresponding to nucleotides 426 to 430, 424 to 430, or 423 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO: 1, respectively.
[0047] (3) A soybean seed comprising the soybean plant cell according to Example 1 or 2.
[0048] (4) A soybean seed batch comprising the soybean seeds described in Example 3.
[0049] (5) The soybean seed lot of embodiment 4, wherein the seeds of the seed lot are homozygous for the mutated JAG1 gene, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, or a polynucleotide sequence comprising SEQ ID NO: 7, and wherein the number of seeds per kilogram of seeds in the seed lot is increased compared to the number of seeds per kilogram of seeds in a corresponding control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
[0050] (6) The soybean seed lot of embodiment 5, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, or a polynucleotide sequence comprising SEQ ID NO: 7, and wherein the number of seeds per kilogram of seeds in the seed lot is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% as compared to the number of seeds per kilogram of seeds in a corresponding control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
[0051] (7) A soybean plant comprising the soybean plant cell according to Example 1 or 2.
[0052] (8) The soybean plant of embodiment 7, wherein the soybean plant is homozygous for the mutated JAG1 gene, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, or a polynucleotide sequence comprising SEQ ID NO: 7, and wherein the number of seeds per kilogram of seeds harvested from the soybean plant is increased compared to seeds harvested from a corresponding control soybean plant lacking the mutated JAG1 gene.
[0053] (9) The soybean plant of embodiment 8, wherein the number of seeds per kilogram of seeds is increased by up to about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% compared to the number of seeds per kilogram of seeds harvested from a corresponding control soybean plant lacking the mutated JAG1 gene.
[0054] (10) A soybean plant part comprising the soybean plant cell of embodiment 1 or 2, wherein the part is a leaf, a stem, a root or a pod.
[0055] (11) A polynucleotide comprising the sequence of SEQ ID NO: 7, 8 or 9, or encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13 or 14.
[0056] (12) A biological sample comprising the polynucleotide described in Example 11.
[0057] (13) The biological sample as described in Example 12, wherein the sample comprises soybean meal or soybean straw.
[0058] (14) A method for producing a soybean seed batch, the method comprising: (i) growing a population of soybean plants comprising a mutated JAG1 gene to maturity, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14 or an allelic variant thereof, and wherein the soybean plants are homozygous for the mutated JAG1 gene; and (ii) harvesting seeds from the soybean plant population of step (i) at maturity, thereby producing the soybean seed batch.
[0059] (15) The method of embodiment 14, wherein the mutated JAG1 gene comprises: (i) a polynucleotide sequence of SEQ ID NO: 7, 8 or 9; or (ii) wherein the allelic variant of SEQ ID NO: 12, 13 or 14 comprises a deletion corresponding to nucleotides 426 to 430, 424 to 430 or 423 to 430 of the endogenous soybean JAG1 gene of SEQ ID NO: 1, respectively.
[0060] (16) The method of embodiment 14, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, or a polynucleotide sequence comprising SEQ ID NO: 7, and wherein the number of seeds per kilogram of seeds in the seed lot is increased compared to a corresponding control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
[0061] (17) The method of embodiment 16, wherein the number of seeds per kilogram of seeds in the seed batch is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% compared to the number of seeds per kilogram of seeds in a control soybean seed batch comprising soybean seeds lacking the mutated JAG1 gene.
[0062] (18) A method for preparing a soybean plant containing a mutant JAG1 gene, the method comprising: (a) deleting: (i) nucleotides 426 to 430 of an endogenous soybean JAG1 gene of SEQ ID NO:1 or an allelic variant thereof in a wild-type soybean plant cell; (ii) nucleotides 424 to 430 of an endogenous soybean JAG1 gene of SEQ ID NO:1 or an allelic variant thereof in a wild-type soybean plant cell; or (iii) nucleotides 423 to 430 of an endogenous soybean JAG1 gene of SEQ ID NO:1 or an allelic variant thereof in a wild-type soybean plant cell; to obtain a modified soybean plant cell comprising the mutant JAG1 gene; and (b) recovering a soybean plant from the modified soybean plant cell.
[0063] (19) The method as described in Example 18, wherein: (a) the nucleotide of (i) is deleted, and the mutated JAG1 gene comprises the polynucleotide sequence of SEQ ID NO:7; (b) the nucleotide of (ii) is deleted, and the mutated JAG1 gene comprises the polynucleotide sequence of SEQ ID NO:8; or (c) the nucleotide of (iii) is deleted, and the mutated JAG1 gene comprises the polynucleotide sequence of SEQ ID NO:9.
[0064] (20) The method of embodiment 18 or 19, wherein the recovering comprises the steps of generating soybean callus from the modified soybean plant cell and generating the soybean plant from the soybean callus.
[0065] (21) The method of embodiment 18, 19 or 20, further comprising the step of harvesting seeds containing the deletion from the soybean plant.
[0066] (22) A method for producing a soybean crop, the method comprising planting a plurality of soybean seeds as described in Example 3 or a seed batch as described in Example 4, 5 or 6.
[0067] (23) The method of Example 22, further comprising harvesting seeds from soybean plants grown from the planted seeds.
[0068] (24) The method of embodiment 23, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, or a polynucleotide sequence comprising SEQ ID NO: 7, and the number of seeds per kilogram of seeds harvested is increased compared to the number of seeds per kilogram of soybean seeds harvested from corresponding control soybean plants grown from control soybean seeds lacking the mutated JAG1 gene.
[0069] (25) The method of embodiment 24, wherein the number of seeds per kilogram of seeds harvested is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% compared to the number of seeds per kilogram of seeds harvested from corresponding control soybean plants grown from control soybean seeds lacking the mutated JAG1 gene.
[0070] (26) A method for producing soybean by-products, the method comprising at least one of the following processing steps: cleaning, cracking, peeling, crushing, soaking, pressing, extracting, draining and / or extruding the seed batch described in Example 4, 5 or 6.
[0071] (27) A method as described in Example 26, wherein the by-product is soy protein, and wherein the soybean seed batch is subjected to the following processing steps: (i) at least one of the steps of cracking, flaking, crushing, pressing and / or soaking; (ii) extracting the cracked, flaked, crushed, pressed and / or soaked soybean seed product from step (i) with an organic solvent to produce defatted soy flour; and (iii) extracting the defatted soy flour from step (ii) with an aqueous solvent to produce an aqueous fraction containing soy protein.
[0072] (28) The method of embodiment 26, wherein the by-product is soybean oil, and wherein the soybean seed batch is pressed to produce the oil.
[0073] (29) A method as described in Example 26, wherein the by-product is soybean oil, and wherein the soybean seed batch is subjected to the following processing steps: (i) at least one of the following cracking, flaking, crushing, pressing and / or soaking steps; and (ii) subjecting the cracked, flaked, crushed, pressed and / or soaked soybean seed product from step (i) to a solvent extraction, drainage and / or extrusion step to produce the oil.
[0074] (30) A guide RNA molecule comprising a spacer RNA molecule encoded by SEQ ID NO:2.
[0075] Additional non-limiting examples of the present disclosure are also provided herein, as follows:
[0076] 1. A soybean plant cell comprising a mutated JAG1 gene, wherein the mutated JAG1 gene comprises a null mutation in the JAG1 gene encoding a polypeptide of SEQ ID NO: 10 or an allelic variant thereof, and wherein the soybean plant cell lacks a loss-of-function mutation in a soybean JAG2 gene.
[0077] 2. The soybean plant cell of embodiment 1, wherein the null mutation comprises a deletion of at least 1 to 16 nucleotides corresponding to nucleotides 421 to 436 of the JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof.
[0078] 3. The soybean plant cell of embodiment 1 or 2, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof.
[0079] 4. The soybean plant cell of any one of embodiments 1-3, wherein said plant cell is homozygous for said mutated JAG1 gene.
[0080] 5. The soybean plant cell of any one of embodiments 1 to 4, wherein the mutated JAG1 gene comprises the polynucleotide sequence of SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35, or an allelic variant thereof.
[0081] 6. The soybean plant cell of any one of embodiments 1 to 5, wherein the soybean plant cell further comprises A2704-12, A5547-127, BPS-CV127-9, DAS44406-6, DAS68416-4, DAS81419-2, DP305423, GTS 40-3-2, HOS, A5547-127, MON87701, MON87705, MON87708, MON87769, MON89788, MON98788, or a SYHT0H210 transgenic event or a modification thereof; and / or wherein (ii) the soybean plant cell further comprises a null allele of the TFL1b gene.
[0082] 7. A soybean seed comprising the soybean plant cell of any one of embodiments 1 to 6.
[0083] 8. A soybean seed lot comprising the soybean seeds of embodiment 7.
[0084] 9. The soybean seed lot of embodiment 8, wherein said seed lot comprises soybean seeds homozygous for said mutated JAG1 gene.
[0085] 10. The soybean seed lot of embodiment 8 or 9, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof, or a polynucleotide sequence comprising SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34, or 35, or an allelic variant thereof.
[0086] 11. The soybean seed lot of any one of embodiments 8-10, wherein the number of seeds per kilogram of seeds in the seed lot is increased compared to a corresponding control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
[0087] 12. The soybean seed lot of any one of embodiments 8 to 10, wherein the number of seeds per kilogram of seeds in the seed lot is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% as compared to the number of seeds per kilogram of seeds in a corresponding control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
[0088] 13. The soybean seed lot of any one of embodiments 8-12, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof, or a polynucleotide sequence comprising SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34, or 35, or an allelic variant thereof.
[0089] 14. A soybean plant comprising the soybean plant cell of any one of embodiments 1-6.
[0090] 15. The soybean plant of embodiment 14, wherein said soybean plant is homozygous for said mutated JAG1 gene.
[0091] 16. The soybean plant of embodiment 14 or 15, wherein the number of seeds per kilogram of seeds harvested from the soybean plant is increased compared to the number of seeds per kilogram of seeds harvested from a corresponding control soybean plant lacking the mutated JAG1 gene.
[0092] 17. The soybean plant of embodiment 14 or 15, wherein the number of seeds per kilogram of seeds is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% as compared to the number of seeds per kilogram of seeds harvested from a corresponding control soybean plant lacking the mutated JAG1 gene.
[0093] 18. The soybean plant of any one of embodiments 14-17, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof, or a polynucleotide sequence comprising SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34, or 35, or an allelic variant thereof.
[0094] 19. A soybean plant part comprising the soybean plant cell of any one of embodiments 1-6, wherein the part is a leaf, stem, root, or pod.
[0095] 20. A polynucleotide comprising a sequence of SEQ ID NO:7, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35 or an allelic variant thereof, or encoding a polypeptide comprising an amino acid sequence of SEQ ID NO:12, 13, 14, 22, 24, 26, 28, 30 or an allelic variant thereof.
[0096] 21. A biological sample comprising the polynucleotide of embodiment 20.
[0097] 22. The biological sample of embodiment 21, wherein the sample comprises soybean meal or soybean straw.
[0098] 23. A method of producing a soybean seed lot, the method comprising: (i) growing a population of soybean plants of any one of embodiments 14-18 to maturity, the soybean plants comprising a mutated JAG1 gene, wherein the soybean plants are homozygous for the mutated JAG1 gene; and (ii) harvesting seeds from the population of soybean plants of step (i) at maturity, thereby producing the soybean seed lot.
[0099] 24. The method of embodiment 23, wherein the mutated JAG1 gene comprises a polynucleotide sequence of SEQ ID NO: 7, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35 or an allelic variant thereof.
[0100] 25. The method of embodiment 23 or 24, wherein the number of seeds per kilogram of seeds in the seed lot is increased compared to the number of seeds per kilogram of seeds in a corresponding control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
[0101] 26. The method of embodiment 23 or 24, wherein the number of seeds per kilogram of seeds in the seed lot is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% as compared to the number of seeds per kilogram of the control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
[0102] 27. The method of any one of embodiments 23 to 26, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof.
[0103] 28. A method for preparing a soybean plant containing a mutant JAG1 gene, the method comprising deleting at least 1 to 16 nucleotides corresponding to nucleotides 421 to 436 of an endogenous soybean JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof in a wild-type soybean plant cell to obtain a modified soybean plant cell comprising the mutant JAG1 gene; and (b) recovering a soybean plant from the modified soybean plant cell.
[0104] 29. The method of embodiment 28, wherein the mutated JAG1 gene comprises a polynucleotide sequence of SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35 or an allelic variant thereof.
[0105] 30. The method of embodiment 28 or 29, wherein said recovering comprises the steps of generating soybean callus from said modified soybean plant cell and generating said soybean plant from said soybean callus.
[0106] 31. The method of embodiment 30, further comprising the step of harvesting seeds comprising the deletion from the soybean plant, and / or further comprising the step of selecting plants lacking the loss-of-function mutation in the soybean JAG2 gene.
[0107] 32. A method of producing a soybean crop, the method comprising planting the seed lot of any one of embodiments 8 to 13.
[0108] 33. The method of embodiment 32, further comprising harvesting seeds from soybean plants grown from the planted seeds. 34. The method of embodiment 32 or 33, wherein the number of seeds per kilogram of seeds harvested is increased compared to the number of seeds per kilogram of soybean seeds harvested from corresponding control soybean plants grown from control soybean seeds lacking the mutated JAG1 gene. 35. The method of embodiment 32 or 33, wherein the number of seeds per kilogram of seeds harvested is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% as compared to the number of seeds per kilogram of said seeds harvested from a corresponding control soybean plant grown from control soybean seeds lacking said mutated JAG1 gene.
[0109] 36. A method for producing a soybean by-product, the method comprising at least one of the following processing steps: cleaning, cracking, flaking, crushing, macerating, pressing, extracting, draining and / or extruding the seed batch of any one of embodiments 8 to 13.
[0110] 37. The method of embodiment 36, wherein the by-product is soy protein, and wherein the soybean seed batch is subjected to processing steps comprising: (i) at least one of a cracking, flaking, crushing, pressing and / or soaking step; (ii) extracting the cracked, flaked, crushed, pressed and / or soaked soybean seed product from step (i) with an organic solvent to produce defatted soy flour; and (iii) extracting the defatted soy flour from step (ii) with an aqueous solvent to produce an aqueous fraction comprising soy protein.
[0111] 38. The method of embodiment 36 or 37, wherein the byproduct is soybean oil, and wherein the soybean seed lot is pressed to produce the oil.
[0112] 39. The method of embodiment 36 or 37, wherein the by-product is soybean oil, and wherein the soybean seed batch is subjected to processing steps comprising: (i) at least one of a cracking, flaking, crushing, pressing and / or macerating step; and (ii) subjecting the cracked, flaked, crushed, pressed and / or macerated soybean seed product from step (i) to a solvent extraction, draining and / or extrusion step to produce the oil.
[0113] 40. A guide RNA molecule comprising a Cas12 direct repeat element operably linked to a spacer RNA molecule encoded by SEQ ID NO: 2. Examples Example 1. Generation of mJAG1 soybean
[0114] Plasmid pIN1340 was created to transform soybean plants and disrupt the open reading frame of the JAGGED1 (Jag1) gene (Glyma.20g116200) (SEQ ID NO: 1) by CRISPR-mediated gene editing. This plasmid was constructed using the strategies and techniques described in: et al., 2017, The Plant Cell. 29(6)1196-1217; DOI:10.1105 / tpc.16.00922. The pIN1340 vector has the following two functional expression cassettes between the right T-DNA border and the left T-DNA border. The tomato ubiquitin gene promoter and 5' untranslated region (UTR) drive the expression of the CRISPR-Cas nuclease transcript. The Cas gene has an SV40 nuclear localization signal (NLS) fused to the 5' end and a nucleoplasmin NLS fused to the 3' end. As shown in WO2021202397, the Cas coding sequence with NLS fusion was codon optimized for soybean expression. The coding sequence is followed by the Arabidopsis heat shock gene terminator. Another expression cassette consisted of the Arabidopsis thaliana U6-26 promoter followed by an RNA polymerase iii termination signal driving expression of a CRISPR guide RNA comprising a crRNA fused to an RNA encoded by the JAG1_g3 (SEQ ID NO: 2) spacer, the crRNA being designed to target the soybean JAG1 gene.
[0115] The other functional elements of the pIN1340 vector are derived from standard Agrobacterium binary transformation plasmids that can replicate in E. coli and Agrobacterium tumefaciens. They are the T-DNA right border sequence (SEQ ID NO: 4), followed by an expression cassette that confers glyphosate resistance to transgenic plants. The cassette consists of the Arabidopsis thaliana ubiquitin 10 gene promoter and 5'UTR, the Agrobacterium species strain CP4 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene, and the pea rib-1,5-bisphosphate carboxylase (rbcS) small subunit gene terminator. The insertion site is followed by the T-DNA left border sequence (SEQ ID NO: 3).
[0116] Plasmid pIN1340 was transformed into Agrobacterium tumefaciens EHA105 (Hood et al., 1993, Transgenic Research. 2:208-218. doi: 10.1007 / BF01977351) by electroporation according to standard techniques. Frozen glycerol stocks were prepared for plant transformation.
[0117] Transgenic T0 soybean events were made by Agrobacterium-mediated transformation with vector pIN1340. Sterilized soybean seeds were soaked in water overnight, and explants were prepared as mature cotyledon halves with pruned hypocotyls. Explants were infected and co-cultivated, bud induction and elongation and selection, rooting and transplanting into soil to produce typical transformation and regeneration steps of T1 seeds (see, for example, Li et al., Optimization of Agrobacterium-Mediated Transformation in Soybean [Optimization of Agrobacterium-mediated transformation in soybean] (2017) Frontiers in Plant Science [Plant Science Frontier] v8 article 246; Pareddy et al. Transgenic Res [Transgenic Research]. June 2020; 29 (3): 267-281. doi: 10.1007 / s11248-020-00198-8).
[0118] T1 progeny of the T0 plants were grown and genotyped by AmpSeq. T1 plants with the following edits shown in Table 2, homozygous or heterozygous as indicated in the following examples, or segregating wild type were selected for phenotypic analysis. Table 2. Gene editing describe SEQ ID NO Wild-type JAG1 DNA fragment (annotated) 5 Wild-type JAG1 peptide fragment encoded by SEQ ID NO:5 6 1:5D mJAG1 deletion 7 -2:7D mJAG1 deletion 8 -3:8D mJAG1 deletion 9 1:5D mJAG1 missing translation product 12 -2:7D mJAG1 missing translation product 13 -3:8D mJAG1 missing translation product 14
[0119] Figure 1 The reference wild-type JAG1 DNA sequence is depicted, and Figure 2 The mJAG1 deletion sequence is depicted. These three deletions produced frameshift mutations, resulting in polypeptides of SEQ ID NOs: 12, 13, and 14. The GmJag2 locus was also sequenced, but no editing was found. Example 2. Performance of mJAG1 soybean
[0120] T1 progeny plants having the genotypes indicated in Table 3 below were grown in the field at sparse density and phenotyped for number of seeds per plant, number of seeds per pod, total seed weight (grams) per plant, and individual seed weight (seed weight / seed number). Table 3. Analysis of T1 progeny plants
[0121] The data indicate that the scored seed phenotypes were not significantly affected by the mJAG1 allele.
[0122] T1 progeny plants with the genotypes indicated in Table 4 below were grown at sparse density in ground and phenotyped for leaf length and width. Leaf measurements were taken at the 5th node approximately 6 weeks after planting and at the 8th node approximately 7 weeks after planting. Table 4. Leaf phenotype
[0123] The data in Table 4 show that the leaves of plants homozygous for the mJAG1 mutation were narrower and elongated. Example 3. Seed size distribution in mJAG1 soybean
[0124] Seed size distribution was measured using round hole sieves with diameters ranging from 3.6 mm (9 / 64 in) to 8.7 mm (22 / 64 in) at intervals of 0.4 or 0.8 mm (Egli et al., Agronomy Journal, Vol. 79, No. 3, 463-467 1987). The sieves were stacked on top of each other with each sample placed on the top sieve.
[0125] For each sieve, the seeds retained on the top of each sieve were weighed. The distribution of seed size is shown in Table 5 below, where the numbers represent the weight (g) of the seed portion retained on a circular sieve of a specified size (in inches) from a 1000 g subsample oscillated on 9 sieves in descending order of size for 5 minutes. One replicate was collected at 6 locations. Table 5. Seed size
[0126] These results show that seed sizes from 1:5D / 1:5D homozygous mJAG1 plants were not significantly smaller than those from wild-type controls. Example 4. Seed weight and yield of mJAG1 soybean grown in different locations
[0127] Plants that are homozygous for the indicated mJAG1 allele and have the same genetic background were grown at different locations, as shown in Table 6 below. In most locations, five subsamples were collected from three replicated plots, and the seeds were weighed and counted. Average 1000-Swt is the weight (in grams) of one thousand seeds. In these tests, the yield per plant or the yield value per plot was similar to a great extent for all these mutants and wild type. Table 6. Seed weight and yield
[0128] These results indicate that seed weight distribution from plants homozygous for the mJAG1 1:5D allele was consistently lower and tighter. Example 5. Generation of additional mJAG1 mutations
[0129] Additional mJAG1 mutant soybean plants were generated essentially as described in Example 1. T1 progeny of the TO plants were grown and genotyped by AmpSeq. T1 and progeny plants homozygous for the following JAG1 gene edits shown in Table 7 were selected for phenotypic analysis. Table 7. Additional mJAG1 mutants Example 6. Comparison of seed per pound of mJAG1 soybeans to controls in 2022 field trials
[0130] In the summer of 2022, plants that were homozygous for the indicated mJAG1 alleles and had the same genetic background were field tested in the central United States. The number of seeds per pound of harvested seeds was determined for each mJAG1 allele and compared with a control that lacked the mJAG1 allele but was otherwise isogenic, as shown in Table 8 below. The number of seeds per pound of seeds for all mJAG1 alleles increased relative to the control of NING1295, TEND2128, TENF2132, and TENG2141T genotypes. The TENF2147L genotype with 1:4D and 1:7D mJAG1 alleles exhibited a reduction in the number of seeds per pound. Table 8. Calculated seeds / lb (from individual seed weight averages) Example 7. Overview of biological sequences provided in the sequence listing
[0131] Table 9 below describes the biological sequences provided herein. Table 9. Biological sequences
[0132] All cited patents and patent disclosures mentioned in this application are incorporated herein by reference in their entirety. All materials and methods disclosed and claimed herein can be prepared and used as indicated by the above disclosure and by example, without the need for too much experimentation. Although the materials and methods disclosed herein have been described in terms of embodiments and illustrative examples, it will be apparent to those skilled in the art that, without departing from the concept, spirit and scope of the disclosure, substitutions and changes can be made to the materials and methods described herein. It is apparent to those skilled in the art that all such similar substitutions and modifications are considered to be within the spirit, scope and concept of the disclosure as enumerated herein in the embodiments of the disclosure and the specification and appended claims.
Claims
1. A soybean plant cell comprising a mutated JAG1 gene, wherein the mutated JAG1 gene comprises a null mutation in the JAG1 gene encoding a polypeptide of SEQ ID NO: 10 or an allelic variant thereof, and wherein the soybean plant cell lacks a loss-of-function mutation in a soybean JAG2 gene.
2. The soybean plant cell of claim 1, wherein the null mutation comprises a deletion of at least 1 to 16 nucleotides corresponding to nucleotides 421 to 436 of the JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof.
3. The soybean plant cell of claim 1, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30 or an allelic variant thereof.
4. The soybean plant cell of claim 1, wherein said plant cell is homozygous for said mutated JAG1 gene.
5. The soybean plant cell of claim 1, wherein the mutated JAG1 gene comprises a polynucleotide sequence of SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35 or an allelic variant thereof.
6. The soybean plant cell of claim 1, wherein the soybean plant cell further comprises A2704-12, A5547-127, BPS-CV127-9, DAS44406-6, DAS68416-4, DAS81419-2, DP305423, GTS 40-3-2, HOS, A5547-127, MON87701, MON87705, MON87708, MON87769, MON89788, MON98788, or a SYHT0H210 transgenic event or a modification thereof; and / or wherein (ii) the soybean plant cell further comprises a null allele of the TFL1b gene.
7. A soybean seed comprising the soybean plant cell according to any one of claims 1 to 6.
8. A soybean seed lot comprising the soybean seeds of claim 7.
9. The soybean seed lot of claim 8, wherein said seed lot comprises soybean seeds homozygous for said mutated JAG1 gene.
10. The soybean seed lot of claim 8, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof, or a polynucleotide sequence comprising SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34, or 35, or an allelic variant thereof.
11. The soybean seed lot of claim 9, wherein the number of seeds per kilogram of seed in the seed lot is increased compared to a corresponding control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
12. The soybean seed lot of claim 9, wherein the number of seeds per kilogram of seeds in the seed lot is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% as compared to the number of seeds per kilogram of seeds in a corresponding control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
13. The soybean seed lot of claim 8, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof, or a polynucleotide sequence comprising SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34, or 35, or an allelic variant thereof.
14. A soybean plant comprising the soybean plant cell of any one of claims 1 to 6.
15. The soybean plant of claim 14, wherein the soybean plant is homozygous for the mutated JAG1 gene.
16. The soybean plant of claim 15, wherein the number of seeds per kilogram of seeds harvested from the soybean plant is increased compared to the number of seeds per kilogram of seeds harvested from a corresponding control soybean plant lacking the mutated JAG1 gene.
17. The soybean plant of claim 15, wherein the number of seeds per kilogram of seeds is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% as compared to the number of seeds per kilogram of seeds harvested from a corresponding control soybean plant lacking the mutated JAG1 gene.
18. The soybean plant of claim 14, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30, or an allelic variant thereof, or a polynucleotide sequence comprising SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34, or 35, or an allelic variant thereof.
19. A soybean plant part comprising the soybean plant cell of any one of claims 1 to 6, wherein the part is a leaf, a stem, a root or a pod.
20. A polynucleotide comprising a sequence of SEQ ID NO:7, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35 or an allelic variant thereof, or encoding a polypeptide comprising an amino acid sequence of SEQ ID NO:12, 13, 14, 22, 24, 26, 28, 30 or an allelic variant thereof.
21. A biological sample comprising the polynucleotide of claim 20.
22. The biological sample of claim 21, wherein the sample comprises soybean meal or soybean straw.
23. A method of producing a soybean seed lot, the method comprising: (i) growing a population of soybean plants as claimed in claim 14 to maturity, said soybean plant population comprising a mutated JAG1 gene, wherein said soybean plants are homozygous for said mutated JAG1 gene; and (ii) harvesting seeds from said soybean plant population of step (i) at maturity, thereby producing said soybean seed batch.
24. The method of claim 23, wherein the mutated JAG1 gene comprises a polynucleotide sequence of SEQ ID NO: 7, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35 or an allelic variant thereof.
25. The method of claim 23, wherein the number of seeds per kilogram of seeds in the seed lot is increased compared to the number of seeds per kilogram of seeds in a corresponding control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
26. The method of claim 23, wherein the number of seeds per kilogram of seeds in the seed lot is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% as compared to the number of seeds per kilogram of the control soybean seed lot comprising soybean seeds lacking the mutated JAG1 gene.
27. The method of claim 23, wherein the mutated JAG1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 12, 13, 14, 22, 24, 26, 28, 30 or an allelic variant thereof.
28. A method for preparing a soybean plant containing a mutant JAG1 gene, the method comprising deleting at least 1 to 16 nucleotides corresponding to nucleotides 421 to 436 of an endogenous soybean JAG1 gene of SEQ ID NO: 1 or an allelic variant thereof in a wild-type soybean plant cell to obtain a modified soybean plant cell comprising the mutant JAG1 gene; and (b) recovering a soybean plant from the modified soybean plant cell.
29. The method of claim 28, wherein the mutated JAG1 gene comprises a polynucleotide sequence of SEQ ID NO: 7, 8, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 32, 33, 34 or 35 or an allelic variant thereof.
30. The method of claim 29, wherein said recovering comprises the steps of: Soybean callus is generated from the modified soybean plant cell and the soybean plant is generated from the soybean callus.
31. The method of claim 30, further comprising the step of harvesting seeds comprising the deletion from the soybean plant and / or further comprising the step of selecting plants lacking the mutation in the soybean JAG2 gene.
32. A method of producing a soybean crop, the method comprising planting the seed lot of claim 9.
33. The method of claim 32, further comprising harvesting seeds from soybean plants grown from the planted seeds.
34. The method of claim 33, wherein the number of seeds per kilogram of seeds harvested is increased compared to the number of seeds per kilogram of soybean seeds harvested from a corresponding control soybean plant grown from control soybean seeds lacking the mutated JAG1 gene.
35. The method of claim 33, wherein the number of seeds per kilogram of seeds harvested is increased by up to about 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12% as compared to the number of seeds per kilogram of said seeds harvested from a corresponding control soybean plant grown from control soybean seeds lacking said mutated JAG1 gene.
36. A method for producing soybean by-products, the method comprising at least one of the following processing steps: cleaning, cracking, flaking, crushing, macerating, pressing, extracting, draining and / or extruding the seed batch of claim 9.
37. The method of claim 36, wherein the by-product is soy protein, and wherein the soybean seed batch is subjected to processing steps comprising: (i) at least one of a cracking, flaking, crushing, pressing and / or macerating step; (ii) extracting the cracked, flaked, crushed, pressed and / or macerated soybean seed product from step (i) with an organic solvent to produce defatted soy flour; and (iii) extracting the defatted soy flour from step (ii) with an aqueous solvent to produce an aqueous fraction comprising soy protein.
38. The method of claim 36, wherein the by-product is soybean oil, and wherein the soybean seed lot is pressed to produce the oil.
39. The method of claim 36, wherein the by-product is soybean oil, and wherein the soybean seed batch is subjected to processing steps comprising: (i) at least one of a cracking, flaking, crushing, pressing and / or macerating step; and (ii) subjecting the cracked, flaked, crushed, pressed and / or macerated soybean seed product from step (i) to a solvent extraction, draining and / or extrusion step to produce the oil.
40. A guide RNA molecule comprising a Cas12 direct repeat element operably linked to a spacer RNA molecule encoded by SEQ ID NO: 2.
Citation Information
Cited By
Gene for regulating soybean density-tolerant plant type and application thereof
CN120020255A
